Due to the spread of COVID-19 Omicron, there are a series of in-house confirmed cases within pharmaceutical bio companies. Pharmaceutical bio companies are responding by operating the Omicron emergency system and granting additional telecommuting to close contacts.

According to the Central Disease Control Headquarters on the 2nd, the number of new confirmed cases as of the 1st was 138,993. Compared to last week (February 25), the number of confirmed patients increased 1.4 times and more than 6.0 times from four weeks ago (February 1st). As a result, the cumulative number of confirmed patients in Korea is 3,273,449.

As the spread of Omicron increases, it is known that confirmed cases occur